上海2株严重急性呼吸综合征冠状病毒2的分离与鉴定
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R373.1

基金项目:

国家重点研发计划(2016YFC1200401),国家科技重大专项(2017ZX10304403-003).


Isolation and identification of two strains of severe acute respiratory syndrome coronavirus 2 from coronavirus disease 2019 patients in Shanghai
Author:
Affiliation:

Fund Project:

Supported by National Key Research and Development Program of China (2016YFC1200401) and National Science and Technology Major Project of China (2017ZX10304403-003).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的 从新型冠状病毒肺炎(COVID-19)患者鼻/咽拭子样本中分离、培养严重急性呼吸综合征冠状病毒2(SARS-CoV-2)。方法 将来自上海市COVID-19患者的3份鼻/咽拭子样本以TPCK胰酶处理,然后接种Vero E6细胞;待大部分细胞出现明显病变时,取细胞培养上清用qRT-PCR法检测病毒核酸,并用反转录PCR扩增病毒受体结合区(RBD)基因片段;将病毒扩增培养后感染接种于96孔板中的Vero E6细胞,观察细胞病变效应,并用免疫荧光法检测病毒蛋白。结果 2份COVID-19患者鼻/咽拭子样本接种的Vero E6细胞出现明显细胞病变效应,细胞培养上清中检测出新复制产生的SARS-CoV-2核酸,扩增出的RBD序列与早期分离出的SARS-CoV-2相应序列完全一致;病毒感染的Vero E6细胞病变迅速,并能与SARS-CoV-2核衣壳蛋白(N蛋白)单克隆抗体、刺突蛋白(S蛋白)单克隆抗体及COVID-19患者恢复期血清发生反应。结论 从2份COVID-19患者鼻/咽拭子样本中成功分离出SARS-CoV-2,为后续开展SARS-CoV-2感染与致病机制研究、防治药物与疫苗的研发奠定了基础。

    Abstract:

    Objective To isolate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from nasal/throat swabs of coronavirus disease 19 (COVID-19) patients. Methods Three nasal/throat swab samples from COVID-19 patients in Shanghai were treated with TPCK trypsin and were used to treat Vero E6 cells inoculated in 96-well plates. When most of the cells showed obvious cytopathy, the cell culture supernatants were collected. We then detected the viral nucleic acid by fluorescent quantitative real-time polymerase chain reaction, and amplified the gene fragment of the virus receptor binding domain (RBD) by reverse transcription polymerase chain reaction. After amplification and culture, the virus was used to infect the Vero E6 cells inoculated in 96-well plates. The cytopathy was observed and the virus protein was detected by immunofluorescence. Results The Vero E6 cells that cultured with two of three nasal/pharyngeal swab samples showed obvious cytopathic effect and newly synthesized viral nucleic acid was detected in the supernatants of the cell culture. The amplified RBD sequence was completely consistent with the corresponding fragment of SARS-CoV-2 isolated earlier. Virusinfected Vero E6 cells showed cytopathies rapidly and could react with the monoclonal antibody against nucleocapsid protein (N protein) and spike protein (S protein) of SARS-CoV-2, and convalescence sera of COVID-19 patients. Conclusion Two SARS-CoV-2 strains were successfully isolated from two nasal/throat swab samples of COVID-19 patients in Shanghai, which provides evidence for the mechanism research on the infection and pathogenesis of SARS-CoV-2 as well as the development of drugs and vaccines against SARS-CoV-2.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-03-28
  • 最后修改日期:2020-04-08
  • 录用日期:2020-04-29
  • 在线发布日期: 2020-05-18
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭